(HealthDay)—Efficient pharmacy benefit management, including increasing use of generic drugs and negotiation of market-based pharmacy dispensing fees, could save Medicaid programs billions of dollars nationwide in the next 10 years, according to a report prepared by the Menges Group and sponsored by the Pharmaceutical Care Management Association.
Researchers from the Menges Group utilized Centers for Medicare & Medicaid Services data on Medicaid fee-for-service pharmacy usage and costs for calendar year 2011. Savings estimates were derived for each state across the period 2014 to 2023.
According to the report, state Medicaid programs could save a total of $74.4 billion across 2014 to 2023 by optimizing pharmacy benefit management tools and strategies. This includes $43 billion in federal savings and $31.4 billion in state savings. Savings strategies include increasing use of generic drugs ($23.5 billion); negotiating market-based pharmacy dispensing fees ($12.5 billion); using limited pharmacy networks ($33.4 billion); encouraging use of more affordable, preferred brands ($2.7 billion); and reducing drug diversion, polypharmacy, fraud, and waste ($2.3 billion).
"The easiest way for Connecticut to reduce costs in Medicaid is to stop overpaying drugstores and start using cutting edge marketplace tools," Mark Merritt, president and chief executive officer of the Pharmaceutical Care Management Association, said in a statement.
Explore further: Public Citizen: State drug fraud cases on the rise